| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PTC THERAPEUTICS INC | 567,683 | 7,953,000 | 13.83% | ||
| 2 | AERIE PHARMACEUTICALS INC | 150,651 | 5,686,000 | 9.89% | ||
| 3 | BIO-RAD LABRATORIES | 30,687 | 5,027,000 | 8.74% | ||
| 4 | AMICUS THERAPEUTICS INC | 618,317 | 4,576,000 | 7.96% | ||
| 5 | CENTENE CORP DEL | 67,856 | 4,544,000 | 7.90% | ||
| 6 | IMPAX LABORATORIES INC | 164,156 | 3,890,000 | 6.76% | ||
| 7 | UNITEDHEALTH GROUP INC | 27,728 | 3,882,000 | 6.75% | ||
| 8 | INCYTE | 37,407 | 3,527,000 | 6.13% | ||
| 9 | JAZZ PHARMACEUTICALS PLC SHS USD | 28,229 | 3,429,000 | 5.96% | ||
| 10 | LILLY ELI & CO | 33,029 | 2,651,000 | 4.61% | ||
| 11 | IRONWOOD PHARMACEUTICALS | 149,720 | 2,378,000 | 4.14% | ||
| 12 | NEUROCRINE BIOSCIE COM USD0.001 | 37,644 | 1,906,000 | 3.31% | ||
| 13 | SYNERGY PHARMACEUTICALS DEL COM NEW | 339,068 | 1,868,000 | 3.25% | ||
| 14 | EDWARDS LIFESCIENCES CORP | 13,908 | 1,677,000 | 2.92% | ||
| 15 | NOVOCURE LTD | 157,176 | 1,342,000 | 2.33% | ||
| 16 | NEVRO CORP | 12,161 | 1,269,000 | 2.21% | ||
| 17 | FLAMEL TECHNOLOGIES | 57,769 | 716,000 | 1.25% | ||
| 18 | GALAPAGOS NV | 6,250 | 404,000 | 0.70% | ||
| 19 | QUEST DIAGNOSTICS | 4,700 | 398,000 | 0.69% | ||
| 20 | GLAUKOS CORP | 10,233 | 386,000 | 0.67% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001657134-16-000007, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
